HMD.AX ASX
HeraMED Limited
1W: -6.7%
1M: +16.7%
3M: +0.0%
YTD: +5.0%
1Y: +23.5%
3Y: -38.7%
5Y: -78.5%
A$0.04 ($0.03)
+0.00 (+2.38%)
Weekly Expected Move ±12.8%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$196K
-13.2% ▼
5Y CAGR: +37.7%
Gross Profit
$100K
-26.2% ▼
Operating Income
-$3M
+52.3% ▲
Net Income
-$3M
+18.9% ▲
EPS (Diluted)
$-0.00
+59.4% ▲
EBITDA
-$3M
+23.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $84K | $216K | $413K | $225K | $196K |
| YoY Growth | +111.8% | +157.9% | +91.5% | -45.4% | -13.2% |
| Cost of Revenue | $303K | $430K | $165K | $90K | $96K |
| Gross Profit | -$219K | -$215K | $248K | $135K | $100K |
| Gross Margin | -262.3% | -99.5% | 60.0% | 60.0% | 51.0% |
| R&D Expenses | $1M | $747K | $1M | $1M | $686K |
| SG&A Expenses | $2M | $2M | $3M | $3M | $2M |
| Operating Expenses | $4M | $3M | $5M | $6M | $3M |
| Operating Income | -$4M | -$3M | -$5M | -$6M | -$3M |
| Operating Margin | -4699.8% | -1466.7% | -1100.1% | -2469.4% | -1358.1% |
| Interest Expense | $2M | $3M | $90K | $48K | $3K |
| Income Before Tax | -$6M | -$5M | -$5M | -$3M | -$3M |
| Tax Expense | $91K | $3 | $0 | $0 | $0 |
| Net Income | -$6M | -$5M | -$5M | -$3M | -$3M |
| Net Margin | -6822.3% | -2261.6% | -1089.8% | -1507.0% | -1408.3% |
| EPS (Diluted) | $-0.04 | $-0.02 | $-0.02 | $-0.01 | $-0.00 |
| EBITDA | -$4M | -$3M | -$4M | -$3M | -$3M |
| Shares Outstanding | 178M | 219M | 260M | 532M | 1.07B |